These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 16970686

  • 1. Retrospective analysis of patients with lupus nephritis: data from a large clinical immunological center in Hungary.
    Brugos B, Kiss E, Szodoray P, Szegedi G, Zeher M.
    Scand J Immunol; 2006 Oct; 64(4):433-7. PubMed ID: 16970686
    [Abstract] [Full Text] [Related]

  • 2. [Lupus nephritis: retrospective analysis of the course of the disease].
    Djukanović L, Pavlović S, Blagojević R, Dimitrijević J, Stojsic T, Ratković M, Kazić K, Lezaić V, Naumović R.
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():26-31. PubMed ID: 12583310
    [Abstract] [Full Text] [Related]

  • 3. [Intermittent intravenous administration of cyclophosphamide in patients with lupus nephritis].
    Morović-Vergles J, Galesić K, Dancuo I, Vergles D.
    Acta Med Croatica; 2004 Aug; 58(1):13-7. PubMed ID: 15125388
    [Abstract] [Full Text] [Related]

  • 4. Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis.
    Couzi L, Merville P, Deminière C, Moreau JF, Combe C, Pellegrin JL, Viallard JF, Blanco P.
    Arthritis Rheum; 2007 Jul; 56(7):2362-70. PubMed ID: 17599764
    [Abstract] [Full Text] [Related]

  • 5. [Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus].
    Serikova SIu, Kozlovskaia NL, Shilov EM.
    Ter Arkh; 2008 Jul; 80(6):52-8. PubMed ID: 18655477
    [Abstract] [Full Text] [Related]

  • 6. Systemic lupus erythematosus in Thai children: clinicopathologic findings and outcome in 82 patients.
    Pattaragarn A, Sumboonnanonda A, Parichatikanond P, Supavekin S, Suntornpoch V, Vongjirad A.
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S232-41. PubMed ID: 16856445
    [Abstract] [Full Text] [Related]

  • 7. [Long-term outcome of paediatric lupus nephritis].
    Casado Picón R, Lumbreras Fernández J, Muley Alonso R, Vara Martín J.
    An Pediatr (Barc); 2010 May; 72(5):317-23. PubMed ID: 20392678
    [Abstract] [Full Text] [Related]

  • 8. Synchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis.
    Danieli MG, Palmieri C, Salvi A, Refe MC, Strusi AS, Danieli G.
    J Clin Apher; 2002 May; 17(2):72-7. PubMed ID: 12210709
    [Abstract] [Full Text] [Related]

  • 9. Outcome of lupus nephritis in Indian children.
    Hari P, Bagga A, Mahajan P, Dinda A.
    Lupus; 2009 Apr; 18(4):348-54. PubMed ID: 19276303
    [Abstract] [Full Text] [Related]

  • 10. Determinants of renal functional outcome in lupus nephritis: a single centre retrospective study.
    Chrysochou C, Randhawa H, Reeve R, Waldek S, Wood GN, O'Donoghue DJ, Kalra PA.
    QJM; 2008 Apr; 101(4):313-6. PubMed ID: 18270227
    [Abstract] [Full Text] [Related]

  • 11. Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure.
    Faurschou M, Starklint H, Halberg P, Jacobsen S.
    J Rheumatol; 2006 Aug; 33(8):1563-9. PubMed ID: 16881113
    [Abstract] [Full Text] [Related]

  • 12. Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multi-ethnic New Zealand cohort.
    Burling F, Ng J, Thein H, Ly J, Marshall MR, Gow P.
    Lupus; 2007 Aug; 16(10):830-7. PubMed ID: 17895308
    [Abstract] [Full Text] [Related]

  • 13. Treatment and renal outcome of lupus nephritis: single center experience.
    Go KW, Teo SM.
    Med J Malaysia; 2006 Oct; 61(4):447-50. PubMed ID: 17243522
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
    Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS, Wong RW, Au TC.
    Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
    [Abstract] [Full Text] [Related]

  • 15. [Lupus nephritis: clinicomorphological manifestations (author's transl)].
    Torras A, Vallés M, Darnell A, Mirapeix E, Revert L.
    Med Clin (Barc); 1980 Jun 10; 75(1):1-9. PubMed ID: 7392705
    [Abstract] [Full Text] [Related]

  • 16. [Long term survival of patients with lupus nephritis].
    Mitić I, Ilić T, Strazmester-Majstorović G, Spasić D, Celić D, Kurjacki B, Stajnic S, Budakov P, Vodopivec S, Sakac V, Djurdjević-Mirković T, Petrović L, Curić S.
    Srp Arh Celok Lek; 2002 Aug 10; 130 Suppl 3():32-7. PubMed ID: 12583311
    [Abstract] [Full Text] [Related]

  • 17. Idiotypic vaccination with a murine anti-dsDNA antibody: phase I study in patients with nonactive systemic lupus erythematosus with nephritis.
    Spertini F, Leimgruber A, Morel B, Khazaeli MB, Yamamoto K, Dayer JM, Weisbart RH, Lee ML.
    J Rheumatol; 1999 Dec 10; 26(12):2602-8. PubMed ID: 10606369
    [Abstract] [Full Text] [Related]

  • 18. Systemic lupus with nephritis: a long-term study.
    Cameron JS, Turner DR, Ogg CS, Williams DG, Lessof MH, Chantler C, Leibowitz S.
    Q J Med; 1979 Jan 10; 48(189):1-24. PubMed ID: 482585
    [Abstract] [Full Text] [Related]

  • 19. Treatment options in lupus nephritis.
    McLigeyo SO.
    East Afr Med J; 1998 Oct 10; 75(10):609-13. PubMed ID: 10065198
    [Abstract] [Full Text] [Related]

  • 20. Outcome of chilean patients with lupus nephritis and response to intravenous cyclophosphamide.
    Velásquez X, Verdejo U, Massardo L, Martínez ME, Arriagada S, Rosenberg H, Valdivieso A, Jacobelli S.
    J Clin Rheumatol; 2003 Feb 10; 9(1):7-14. PubMed ID: 17041416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.